DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Kaletra (Lopinavir / Ritonavir) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (28)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Kaletra (Lopinavir / Ritonavir) disability. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Kaletra side effects in male

Reported by a physician from Japan on 2012-08-24

Patient: male, weighing 59.5 kg (130.9 pounds)

Reactions: Pulmonary Hypertension, Hepatic Function Abnormal, Fibrin Degradation Products Increased, Nausea, Tremor, Palpitations, Visual Impairment, Dizziness, Nervous System Disorder, Influenza Like Illness

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Abacavir Sulfate
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-07-24
    End date: 2000-07-25

Abacavir Sulfate
    Administration route: Oral
    Start date: 2001-10-20
    End date: 2001-10-27

Didanosine
    Administration route: Oral
    Start date: 2001-07-21
    End date: 2004-05-14

Didanosine
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1994-11-19
    End date: 2001-07-21

Efavirenz
    Administration route: Oral
    Start date: 2000-09-25
    End date: 2000-10-02

Efavirenz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-07-24
    End date: 2000-07-25

Indinavir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-03-08
    End date: 2000-05-24

Kaletra
    Administration route: Oral
    Indication: HIV Infection
    End date: 2004-04-24

Lamivudine
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-05-15
    End date: 2008-09-19

Norvir
    Administration route: Oral
    Start date: 2008-09-20

Norvir
    Administration route: Oral
    Start date: 2004-04-25
    End date: 2008-09-19

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-06-19
    End date: 2000-12-24

Peginterferon Alfa-2B
    Indication: Hepatitis C
    Start date: 2002-08-17
    End date: 2003-07-12

Saquinavir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-06-19
    End date: 2000-03-18

Saquinavir
    End date: 2001-03-31

Saquinavir
    Administration route: Oral
    Start date: 2000-05-24
    End date: 2000-12-24

Stavudine
    Dosage: daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-08-25
    End date: 2001-10-20

Other drugs received by patient: Truvada; Amlodipine Besylate; Lexiva; Coagulation Factor Viii; Olmesartan Medoxomil; Tenofovir Disoproxil Fumarate; Isentress; Cross Eight M; Ribavirin; Coagulation Factor Viii; Ribavirin; Atazanavir



Possible Kaletra side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Diabetes Mellitus, Hypertriglyceridaemia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Epivir
    Dosage: 150 mg, bid
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2003-09-16
    End date: 2006-02-28

Epivir
    Dosage: 150 mg, bid
    Administration route: Oral
    Start date: 2008-12-16

Intelence
    Dosage: 200 mg, bid
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2009-02-11

Isentress
    Dosage: 800 mg divided dose frequency u
    Administration route: Oral
    Start date: 2008-08-05

Kaletra
    Dosage: 4 df
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-07-04
    End date: 2008-01-08

Prezista
    Dosage: 1200 mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-01-09
    End date: 2008-05-01

Truvada
    Dosage: 1 df, unk
    Administration route: Oral
    Start date: 2008-08-05
    End date: 2008-12-15

Truvada
    Dosage: 1df
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-07-04
    End date: 2008-05-01

Zerit
    Dosage: 60 mg divided dose frequency u
    Administration route: Oral
    Start date: 2008-12-16
    End date: 2009-02-10

Zerit
    Dosage: 80 mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2003-09-16
    End date: 2006-02-28

Other drugs received by patient: Rhythmy



Possible Kaletra side effects in 24 year old male

Reported by a consumer/non-health professional from United States on 2012-08-21

Patient: 24 year old male

Reactions: Pulmonary Hypertension, Palpitations, Dizziness

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Crixivan
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-03-18
    End date: 2000-05-24

Efavirenz
    Dosage: interrupted from 07/25/00 to 09/25/00 24jul-25jul2000,25sep-02oct2000. film coated tab 200 mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-07-24
    End date: 2000-10-02

Epivir
    Dosage: tabs
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-05-15
    End date: 2008-09-19

Invirase
    Dosage: inter:03/18/00-05/24/00,caps 800mg:19jun99-18mar2000.divided dse:24may00-24dec2000,19jun1999-24dc00
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-06-19
    End date: 2001-03-31

Kaletra
    Dosage: 1df,25dec2000-24apr2004:1217 days
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-12-25
    End date: 2004-04-24

Norvir
    Dosage: 31mar2001(interrupted).caps 800mg:19jun99-31oct-99.divided dose:01nov99-24dec2000.25apr2004
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-06-19
    End date: 2008-09-19

Videx
    Dosage: 250,300,400mg12/19/94-3/7/97,3/07/97-7/21/01,7/21/01,125mg,19dc94-7mar97(810d),7mr97-21jl01(1598d)
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1994-12-19
    End date: 2001-07-21

Videx EC
    Dosage: divided dose
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-07-21
    End date: 2004-05-14

Zerit
    Dosage: 60 mg 8/25/97-27/2/98, 80 mg 2/27-8/3/98, 11/9/98 -6/19/99 and 12/25/00-10/20/01
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-08-25
    End date: 2001-10-20

Ziagen
    Dosage: interrupted from 07/25/00 to 10/20/01 tabs24jul-25jul2000.20oct2001-27oct2001.
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-07-24
    End date: 2001-10-27

Other drugs received by patient: Cross Eight M



Possible Kaletra side effects in male

Reported by a physician from Japan on 2012-08-01

Patient: male

Reactions: Hepatitis C

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Kaletra
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-12-20

Kaletra

Other drugs received by patient: Didanosine; Didanosine; Tenofovir Disoproxil Fumarate



Possible Kaletra side effects in 59 year old male

Reported by a physician from Japan on 2012-07-10

Patient: 59 year old male

Reactions: LIP Swelling, Hypersensitivity, Rash Generalised, Stomatitis, Blood Triglycerides Increased, Oropharyngeal Pain

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Abacavir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-07-18
    End date: 2008-07-27

Abacavir
    Start date: 2008-07-29

Kaletra
    Administration route: Oral
    Start date: 2008-07-29

Kaletra
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-07-18
    End date: 2008-07-27

Lamivudine
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-07-18
    End date: 2008-07-27

Lamivudine
    Start date: 2008-07-29

Other drugs received by patient: Tenofovir Disoproxil Fumarate; Metoclopramide; Sulfamethoxazole and Trimethoprim; Loperamide HCL



Possible Kaletra side effects in 20 year old male

Reported by a health professional (non-physician/pharmacist) on 2012-06-29

Patient: 20 year old male, weighing 73.0 kg (160.6 pounds)

Reactions: Neutropenia, Ill-Defined Disorder

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Cidofovir
    Dosage: 52.8571 mg (370 mg, 1 in 1 wk), intravenous
    Indication: JC Virus Infection
    Start date: 2012-03-28
    End date: 2012-04-23

Cidofovir
    Dosage: 52.8571 mg (370 mg, 1 in 1 wk), intravenous
    Indication: Progressive Multifocal Leukoencephalopathy
    Start date: 2012-03-28
    End date: 2012-04-23

Kaletra
    Dosage: 4 dosage forms (2 dosage forms, 2 in 1 d), oral
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-14

Zidovudine
    Dosage: 500 mg (250 mg, 2 in 1 d), oral
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-14
    End date: 2012-04-06

Other drugs received by patient: Probenecid; Mirtazapine; Saquinavir (Saquinavir); Tenofovir (Tenofovir)



Possible Kaletra side effects in 20 year old male

Reported by a pharmacist from United Kingdom on 2012-06-28

Patient: 20 year old male

Reactions: Neutropenia, Ill-Defined Disorder

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Kaletra
    Dosage: 2 df, bid
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-14

Vistide
    Dosage: 370 mg, q1wk
    Indication: Progressive Multifocal Leukoencephalopathy
    Start date: 2012-03-28
    End date: 2012-04-23

Vistide
    Indication: JC Virus Infection

Zidovudine
    Dosage: 250 mg, bid
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-14
    End date: 2012-04-06

Other drugs received by patient: Saquinavir; Tenofovir Disoproxil Fumarate; Probenecid; Mirtazapine; Probenecid; Probenecid



Possible Kaletra side effects in 20 year old male

Reported by a pharmacist from United Kingdom on 2012-06-27

Patient: 20 year old male, weighing 73.0 kg (160.6 pounds)

Reactions: Neutropenia, Ill-Defined Disorder

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Cidofovir
    Dosage: 370mg weekly
    Indication: Progressive Multifocal Leukoencephalopathy
    Start date: 2012-03-28
    End date: 2012-04-23

Cidofovir
    Indication: JC Virus Infection

Kaletra
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-14

Zidovudine
    Dosage: 250mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-14
    End date: 2012-04-06

Other drugs received by patient: Saquinavir; Probenecid; Mirtazapine; Tenofovir Disoproxil Fumarate



Possible Kaletra side effects in male

Reported by a physician from Japan on 2012-06-26

Patient: male

Reactions: Osteonecrosis, Epilepsy, Extradural Haematoma

Adverse event resulted in: death, hospitalization, disablity

Drug(s) suspected as cause:
Efavirenz
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-02-05
    End date: 2002-11-23

Epivir
    Dosage: 300 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-02-05
    End date: 2002-11-23

Kaletra
    Dosage: 4 df, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-10-24
    End date: 2008-10-27

Kaletra
    Dosage: 6 df, qd
    Administration route: Oral
    Start date: 2002-11-24
    End date: 2006-10-23

Prezista
    Dosage: 1200 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-10-28
    End date: 2010-05-18

Ritonavir
    Dosage: 200 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-10-28
    End date: 2010-05-18

Tenofovir Disoproxil Fumarate
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-11-25

Zerit
    Dosage: 80 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-02-05
    End date: 2002-11-23

Other drugs received by patient: Clonazepam; Bufferin; Primidone; Primidone; Anafranil; Bromvalerylurea; Loperamide Hydrochloride; Ganaton; Depakene; LAC B; Merislon



Possible Kaletra side effects in male

Reported by a physician from Canada on 2012-05-30

Patient: male, weighing 55.4 kg (121.9 pounds)

Reactions: Weight Decreased, Dysphagia, Wrong Technique in Drug Usage Process, Gastric Operation, Oesophageal Carcinoma, Abdominal Discomfort, Oesophageal Food Impaction, Oesophagectomy

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Kaletra
    Dosage: 200 mg/ 50 mg, 2 tabs in 1 day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-05-23

Kaletra
    Indication: Antiretroviral Therapy

Kaletra
    Indication: HIV Infection
    End date: 2012-02-13

Kaletra
    Indication: Antiretroviral Therapy

Other drugs received by patient: Truvada; Viread; Aspirin; Viramune; Metoprolol Tartrate; Lipitor



Possible Kaletra side effects in 52 year old male

Reported by a physician from United Kingdom on 2012-05-07

Patient: 52 year old male, weighing 68.0 kg (149.6 pounds)

Reactions: Weight Decreased, Renal Cancer Metastatic, Lymphadenopathy, Lung Neoplasm, Renal Mass, Metastases To Bone, Metastases To Lung

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Abacavir Sulfate / Lamivudine; Opioids; Analgesia



Possible Kaletra side effects in 52 year old male

Reported by a physician from United Kingdom on 2012-05-02

Patient: 52 year old male, weighing 68.0 kg (149.6 pounds)

Reactions: Weight Decreased, Renal Cancer Metastatic, Lymphadenopathy, Lung Neoplasm, Metastases To Bone, Renal Mass, Metastases To Lung

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Analgesia; Abacavir Sulfate / Lamivudine; Opioids



Possible Kaletra side effects in male

Reported by a physician from France on 2012-03-26

Patient: male

Reactions: Aphasia, Hemiplegia, Cerebrovascular Accident

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-07-05

Kaletra
    Dosage: 250mg/50mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-07-05

Viread
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-07-05

Other drugs received by patient: Crestor



Possible Kaletra side effects in male

Reported by a physician from France on 2012-03-23

Patient: male

Reactions: Cerebrovascular Accident

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
    Dosage: 1unit per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-07-05

Kaletra
    Dosage: 4unit per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-07-05

Viread
    Dosage: 1unit per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-07-05

Other drugs received by patient: Crestor



Possible Kaletra side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-21

Patient: male

Reactions: Cerebrovascular Accident

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-07-05

Kaletra
    Dosage: 4 df, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-07-05

Viread
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-07-05

Other drugs received by patient: Crestor



Possible Kaletra side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-19

Patient: male

Reactions: Optic Atrophy, Glaucoma, Trigeminal Neuralgia, Visual Acuity Reduced, Optic Neuritis, Treatment Noncompliance, Optic Neuropathy, Mononeuropathy, AIDS Encephalopathy, Balance Disorder, Leukoencephalopathy, Viral Load Increased, Visual Field Defect, Mass, Viral Load Decreased, Psoriasis, Scotoma, Toxicity To Various Agents, Sensory Disturbance, Visual Impairment, CD4 Lymphocytes Abnormal, Memory Impairment, Asthenia, Anogenital Warts, Neuralgia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Fosamprenavir Calcium
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2005-03-29
    End date: 2006-06-23

Gabapentin
    Administration route: Oral
    Indication: Trigeminal Neuralgia
    Start date: 2006-01-01

Kaletra
    Start date: 2003-01-03

Kaletra
    Start date: 2003-09-12

Kaletra
    Indication: HIV Infection
    Start date: 2000-09-01

Lamivudine + Zidovudine
    End date: 2006-06-23

Lamivudine + Zidovudine
    Start date: 2001-03-23

Lamivudine + Zidovudine
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1999-05-11
    End date: 1999-08-01

Lamivudine + Zidovudine
    Start date: 2005-09-28

Norvir
    Start date: 2002-03-18

Norvir
    Start date: 2004-04-17

Norvir
    Start date: 2004-10-15

Norvir
    Start date: 2005-09-28

Norvir
    Start date: 2005-03-29

Norvir
    Start date: 2006-06-23

Norvir
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1999-09-21

Norvir
    Start date: 2005-06-17

Norvir
    Start date: 2000-06-06

Norvir
    Start date: 2001-03-23

Pregabalin
    Administration route: Oral
    Indication: Trigeminal Neuralgia
    Start date: 2006-06-23
    End date: 2006-07-13

Saquinavir
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1997-03-19

Saquinavir
    Start date: 2006-06-23

Sulfamethoxazole + Trimethoprim
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 1998-09-01

Sulfamethoxazole + Trimethoprim
    Start date: 2002-03-18

Sulfamethoxazole + Trimethoprim
    Start date: 2005-09-28

Sulfamethoxazole + Trimethoprim
    Start date: 2006-06-23

Sulfamethoxazole + Trimethoprim
    Start date: 1998-10-27

Tenofovir Disoproxil Fumarate
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2002-03-18

Tenofovir Disoproxil Fumarate
    Start date: 2003-01-03

Tenofovir Disoproxil Fumarate
    Start date: 2003-09-12

Tenofovir Disoproxil Fumarate
    Start date: 2005-06-17

Tenofovir Disoproxil Fumarate
    Start date: 2006-06-23

Tenofovir Disoproxil Fumarate
    Start date: 2004-04-17

Tenofovir Disoproxil Fumarate
    Start date: 2004-10-15

Tenofovir Disoproxil Fumarate
    Start date: 2005-09-28

Tenofovir Disoproxil Fumarate
    Start date: 2005-03-29

Zidovudine
    Start date: 2006-06-23

Zidovudine
    Start date: 2005-09-28

Zidovudine
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1992-01-01
    End date: 1997-01-01

Zidovudine
    Start date: 2005-06-17

Other drugs received by patient: Stavudine; Didanosine; Lamivudine; Atazanavir; Stavudine; Indinivir Sulfate; Indinivir Sulfate; Didanosine; Didanosine; Amprenavir; Stavudine; Stavudine; Didanosine; Amprenavir; Atazanavir; Cyamemazine; Didanosine; Enfuvirtide; Enfuvirtide; Stavudine; Stavudine; Stavudine; Indinivir Sulfate; Abacavir; Amitriptyline HCL; Lamivudine; Amprenavir; Amprenavir



Possible Kaletra side effects in male

Reported by a consumer/non-health professional from Japan on 2012-02-07

Patient: male

Reactions: Osteonecrosis, Epilepsy

Adverse event resulted in: death, hospitalization, disablity

Drug(s) suspected as cause:
Efavirenz
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-02-05
    End date: 2002-11-23

Epivir
    Dosage: 300 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-02-05
    End date: 2002-11-23

Kaletra
    Dosage: 6 df, qd
    Administration route: Oral
    Start date: 2002-11-24
    End date: 2006-10-23

Kaletra
    Dosage: 4 df, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-10-24
    End date: 2008-10-27

Prezista
    Dosage: 1200 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-10-28
    End date: 2010-05-18

Ritonavir
    Dosage: 200 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-10-28
    End date: 2010-05-18

Tenofovir Disoproxil Fumarate
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-11-25

Zerit
    Dosage: 80 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-02-05
    End date: 2002-11-23

Other drugs received by patient: Primidone; Depakene; Bufferin; Clonazepam; Bromvalerylurea; Merislon; LAC B; Primidone; Loperamide HCL; Ganaton; Anafranil



Possible Kaletra side effects in male

Reported by a physician from Japan on 2012-02-01

Patient: male

Reactions: Osteonecrosis, Epilepsy

Adverse event resulted in: death, hospitalization, disablity

Drug(s) suspected as cause:
Efavirenz
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-02-05
    End date: 2002-11-23

Epivir
    Dosage: 300 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-02-05
    End date: 2002-11-23

Kaletra
    Dosage: 4 df, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-10-24
    End date: 2008-10-27

Kaletra
    Dosage: 6 df, qd
    Administration route: Oral
    Start date: 2002-11-24
    End date: 2006-10-23

Prezista
    Dosage: 1200 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-10-28
    End date: 2010-05-18

Ritonavir
    Dosage: 200 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-10-28
    End date: 2010-05-18

Tenofovir Disoproxil Fumarate
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-11-25

Zerit
    Dosage: 80 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-02-05
    End date: 2002-11-23

Other drugs received by patient: Primidone; Depakene; Bufferin; LAC B; Anafranil; Bromvalerylurea; Loperamide HCL; Merislon; Primidone; Clonazepam; Ganaton



Possible Kaletra side effects in male

Reported by a physician from Mexico on 2012-01-16

Patient: male

Reactions: Weight Decreased, Drug Resistance, Dyslipidaemia, Diarrhoea, Faecal Incontinence, Kaposi's Sarcoma

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Enterogermina; Truvada; Calcium Carbonate



Possible Kaletra side effects in male

Reported by a physician from France on 2012-01-13

Patient: male

Reactions: Confusional State, Blood Creatine Phosphokinase Increased, Dreamy State, Quality of Life Decreased, Coma, Corneal Disorder, Eye Infection, Abdominal Pain Upper, Overdose, Bronchial Disorder, Hypoxia, Oral Mucosa Erosion, Stevens-Johnson Syndrome, Renal Disorder, Toxic Epidermal Necrolysis, Cardiogenic Shock, Odynophagia, Nosocomial Infection, Eye Pain, Anxiety, Lung Disorder, Dysuria, Pharyngeal Erosion, DRY Eye

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Kaletra
    Dosage: 200/50mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-02-05
    End date: 2008-03-06

Truvada
    Dosage: 200mg/245mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-02-05
    End date: 2008-03-06

Other drugs received by patient: Primperan TAB; Magnesium Hydroxide TAB; Alprazolam; Raltegravir; Gaviscon; PPI; Maraviroc; Enfuvirtide; Acetaminophen; Aspirin



Possible Kaletra side effects in male

Reported by a physician from France on 2011-12-16

Patient: male

Reactions: Confusional State, Blood Creatine Phosphokinase Increased, Dreamy State, Quality of Life Decreased, Coma, Corneal Disorder, Eye Infection, Abdominal Pain Upper, Overdose, Bronchial Disorder, Hypoxia, Oral Mucosa Erosion, Stevens-Johnson Syndrome, Renal Disorder, Toxic Epidermal Necrolysis, Nosocomial Infection, Odynophagia, Cardiogenic Shock, Eye Pain, Anxiety, Lung Disorder, Dysuria, Pharyngeal Erosion, DRY Eye

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Kaletra
    Dosage: 200/50mg (unit dose)
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-02-05
    End date: 2008-02-28

Truvada
    Dosage: 200mg/245mg (unit dose)
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-02-05
    End date: 2008-02-28

Other drugs received by patient: Raltegravir; Maraviroc; Primperan TAB; Magnesium Hydroxide TAB; Aspirin; PPI; Enfuvirtide; Gaviscon; Acetaminophen



Possible Kaletra side effects in male

Reported by a physician from Japan on 2011-12-13

Patient: male

Reactions: Pulmonary Hypertension, Hepatic Function Abnormal, Fibrin Degradation Products Increased, Nausea, Tremor, Palpitations, Visual Impairment, Nervous System Disorder, Dizziness, Influenza Like Illness

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Abacavir Sulfate
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-07-24
    End date: 2000-07-25

Abacavir Sulfate
    Administration route: Oral
    Start date: 2001-10-20
    End date: 2001-10-27

Didanosine
    Administration route: Oral
    Start date: 2001-07-21
    End date: 2004-05-14

Didanosine
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1994-11-19
    End date: 2001-07-21

Efavirenz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-07-24
    End date: 2000-07-25

Efavirenz
    Administration route: Oral
    Start date: 2000-09-25
    End date: 2000-10-02

Indinivir Sulfate
    Indication: HIV Infection
    Start date: 2000-03-08
    End date: 2000-05-24

Kaletra
    Administration route: Oral
    Indication: HIV Infection
    End date: 2004-04-24

Lamivudine
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-05-15
    End date: 2008-09-19

Norvir
    Administration route: Oral
    Start date: 2004-04-25
    End date: 2008-09-19

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-06-19
    End date: 2000-12-24

Norvir
    Administration route: Oral
    Start date: 2008-09-20

Peginterferon Alfa-2B
    Indication: Hepatitis C
    Start date: 2002-08-17
    End date: 2003-07-12

Saquinavir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-06-19
    End date: 2000-03-18

Saquinavir
    Administration route: Oral
    Start date: 2000-05-24
    End date: 2000-12-24

Stavudine
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-04-01
    End date: 2001-10-20

Other drugs received by patient: Ribavirin; Isentress; Amlodipine Besylate; Coagulation Factor Viii; Lexiva; Olmesartan Medoxomil; Tenofovir; Coagulation Factor Viii; Ribavirin; Atazanavir; Truvada



Possible Kaletra side effects in 24 year old male

Reported by a consumer/non-health professional from United States on 2011-12-07

Patient: 24 year old male

Reactions: Pulmonary Hypertension, Palpitations, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Dizziness

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Crixivan
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-03-18
    End date: 2000-05-24

Efavirenz
    Dosage: 24-25jul00(2d)-600mg 25sep00-02oct00(8d)
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-07-24
    End date: 2000-10-02

Epivir
    Dosage: tab
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-05-15
    End date: 2008-09-19

Invirase
    Dosage: caps; 19jun99-18mar00(274d) 24may00-24dec00(215d)800mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-06-19
    End date: 2000-12-24

Kaletra
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-12-25
    End date: 2004-04-24

Norvir
    Dosage: 19jun-31oct99;400mg 01nov99-24dec00;420d 100mg/d 24apr05-19sep08;1244d 200mg/d 20sep08-cont
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-06-19

Videx
    Dosage: 19dec94-7mar97(125mg)810d 8mar97-21jul01(300mg)1597d 22jul-14may04(400mg)1028d
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1994-11-19
    End date: 2004-05-14

Zerit
    Dosage: 25aug97-27feb98(187d) 27feb-03aug98(158) 3aug-9nov(99) 9nov98-19jn99(223) 25dc00-20oc01(300d)
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-08-25
    End date: 2001-10-20

Ziagen
    Dosage: 24jul-25jul00(2d)600mg 20oct-27oct01(8d)600mg interrupted on 25jul00
    Administration route: Oral
    Start date: 2000-07-24
    End date: 2001-10-27

Other drugs received by patient: Cross Eight M



Possible Kaletra side effects in 24 year old male

Reported by a individual with unspecified qualification from Japan on 2011-12-06

Patient: 24 year old male

Reactions: Pulmonary Hypertension, Palpitations, Dizziness, Apparent Life Threatening Event

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Crixivan
    Dosage: 800 mg/daily po
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-03-18
    End date: 2000-05-24

Efavirenz
    Dosage: 600 mg/daily po ; 600 mg/daily po
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-09-25
    End date: 2000-10-02

Efavirenz
    Dosage: 600 mg/daily po ; 600 mg/daily po
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-07-24
    End date: 2000-07-25

Invirase
    Dosage: 400 mg/bid po ; 800 mg/daily po
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-06-19
    End date: 2000-03-18

Invirase
    Dosage: 400 mg/bid po ; 800 mg/daily po
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-05-24
    End date: 2000-12-24

Kaletra
    Dosage: 6 dose/daily po
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-12-25
    End date: 2004-04-24

Lamivudine
    Dosage: 300 mg/daily po
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-05-15
    End date: 2008-09-19

Norvir
    Dosage: 400 mg/bid po ; 800 mg/daily po ; 100 mg/daily po ; 200 mg/daily po
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-06-19
    End date: 1999-10-31

Norvir
    Dosage: 400 mg/bid po ; 800 mg/daily po ; 100 mg/daily po ; 200 mg/daily po
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-09-20

Norvir
    Dosage: 400 mg/bid po ; 800 mg/daily po ; 100 mg/daily po ; 200 mg/daily po
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2008-09-19

Norvir
    Dosage: 400 mg/bid po ; 800 mg/daily po ; 100 mg/daily po ; 200 mg/daily po
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-11-01
    End date: 2000-12-24

Videx
    Dosage: 400 mg/daily po
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-07-21
    End date: 2004-05-14

Videx
    Dosage: 125 mg/bid po ; 300 mg/daily po
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1994-12-19
    End date: 1997-03-07

Videx
    Dosage: 125 mg/bid po ; 300 mg/daily po
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-03-07
    End date: 2001-07-21

Zerit
    Dosage: 30 mg/bid po ; 40 mg/bid po ; 30 mg/bid po ; 40 mg/bid po ; 80 mg/daily po
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-02-27
    End date: 1998-08-03

Zerit
    Dosage: 30 mg/bid po ; 40 mg/bid po ; 30 mg/bid po ; 40 mg/bid po ; 80 mg/daily po
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-08-25
    End date: 1998-02-27

Zerit
    Dosage: 30 mg/bid po ; 40 mg/bid po ; 30 mg/bid po ; 40 mg/bid po ; 80 mg/daily po
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-08-03
    End date: 1998-11-09

Zerit
    Dosage: 30 mg/bid po ; 40 mg/bid po ; 30 mg/bid po ; 40 mg/bid po ; 80 mg/daily po
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-11-09
    End date: 1999-06-19

Zerit
    Dosage: 30 mg/bid po ; 40 mg/bid po ; 30 mg/bid po ; 40 mg/bid po ; 80 mg/daily po
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-12-25
    End date: 2001-10-20

Ziagen
    Dosage: 600 mg/daily po ; 600 mg/daily po
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-07-24
    End date: 2000-07-25

Ziagen
    Dosage: 600 mg/daily po ; 600 mg/daily po
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-10-20
    End date: 2001-10-27

Other drugs received by patient: Antihemophilic Factor (Human)



Possible Kaletra side effects in male

Reported by a lawyer from France on 2011-12-05

Patient: male

Reactions: Confusional State, Blood Creatine Phosphokinase Increased, Dreamy State, Quality of Life Decreased, Coma, Corneal Disorder, Eye Infection, Abdominal Pain Upper, Overdose, Bronchial Disorder, Hypoxia, Oral Mucosa Erosion, Stevens-Johnson Syndrome, Renal Disorder, Toxic Epidermal Necrolysis, Nosocomial Infection, Odynophagia, Cardiogenic Shock, Eye Pain, Anxiety, Lung Disorder, Dysuria, Pharyngeal Erosion, DRY Eye

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Kaletra
    Dosage: 200/50mg (unit dose)
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-02-05
    End date: 2008-02-28

Truvada
    Dosage: 200mg/245mg (unit dose)
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-02-05
    End date: 2008-02-28

Other drugs received by patient: Maraviroc; Enfuvirtide; Magnesium Hydroxide TAB; Aspirin; PPI; Gaviscon; Raltegravir; Acetaminophen; Primperan TAB



Possible Kaletra side effects in male

Reported by a physician from Mexico on 2011-11-28

Patient: male

Reactions: Weight Decreased, Drug Resistance, Dyslipidaemia, Diarrhoea, Kaposi's Sarcoma, Faecal Incontinence

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Truvada; Calcium Carbonate; Enterogermina



Possible Kaletra side effects in male

Reported by a individual with unspecified qualification from United States on 2011-11-23

Patient: male, weighing 68.0 kg (149.7 pounds)

Reactions: Weight Decreased, Nausea, Paraesthesia, Burning Sensation, Fatigue, Neuropathy Peripheral, Diarrhoea, Peroneal Nerve Palsy, Gait Disturbance, Lethargy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Kaletra
    Dosage: 200 - 50 mg 1 tab q day po
    Administration route: Oral
    Indication: Injury Associated With Device
    Start date: 2011-06-03
    End date: 2011-07-02

Truvada
    Dosage: 200 - 300 mg 2 tabs bid po
    Administration route: Oral
    Indication: Injury Associated With Device
    Start date: 2011-06-03
    End date: 2011-07-02



Possible Kaletra side effects in male

Reported by a lawyer from France on 2011-11-04

Patient: male

Reactions: Quality of Life Decreased, Coma, Corneal Disorder, Eye Infection, Stevens-Johnson Syndrome

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Kaletra
    Dosage: 200/50mg (unit dose)
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-02-05
    End date: 2008-02-28

Truvada
    Dosage: 200mg/245mg (unit dose)
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-02-05
    End date: 2008-02-28

Other drugs received by patient: Raltegravir; Maraviroc; Enfuvirtide

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012